Discover the Evexia advantage Start ordering today
Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.
Register NowOverview:
The Lyme Broad Coverage Antibody (BCA) Assay is a qualitative test designed to detect IgM and IgG antibodies to Lyme Borreliae group-specific antigens in human serum. The sensitivity of the Lyme BCA Assay is 90%, and the specificity is 97%.
Principle: The test detects IgM and IgG antibodies to the Lyme Borreliae group, and should be used in conjunction with patient clinical symptoms and history.
Stage of Disease: Any Stage of Disease
Test Methodology: ImmunoBlot
Collection Instructions:
Specimen: 1 SST/ minimum volume 0.5mL serum
Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.
Register Now